Clinical Observation of Esophageal Carcinoma Treated with Radiotherapy Combined with Chemotherapy
Xibing Zhuang
Abstract
Xibing Zhuang
Abstract
Objective:To evaluate the efficacy of radiotherapy combined with chemotherapy with Cisplatin,Vinorelbine for the advanced stage of esophageal carcinoma.Methods:Sixty-two patients were randomly divided into radiotherapy combined with chemotherapy group(study group,n=30)and pure radiotherapy group(control group,n=32),The study group were re- ceived 3~4 cycles of NP chemotherapy.while the control group were only given radiotherapy.Results:The short-term effect rate of the two group were 83.0% and 78.0%,respectively survival rates of one,two and three years were 76.6%,55.5%,40. 05 and 49.0%,31.0%,21.0%(P0.05).respectively disease free survival rates of one,two and three years were 70.2%, 43.2%,22.0% and 42.0%,20.5%,18.0%(P0.05).respectively survival rate and disease free survival rate of study group were higher than control group.The side effect of study group(30.0%)was higher than control group(6.3%)(P0.05).Con- clusion:Radiotherapy combined with chemotherapy for esophageal carcinoma has synergistic action.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To evaluate the efficacy of radiotherapy combined with chemotherapy with Cisplatin,Vinorelbine for the advanced stage of esophageal carcinoma.Methods:Sixty-two patients were randomly divided into radiotherapy combined with chemotherapy group(study group,n=30)and pure radiotherapy group(control group,n=32),The study group were re- ceived 3~4 cycles of NP chemotherapy.while the control group were only given radiotherapy.Results:The short-term effect rate of the two group were 83.0% and 78.0%,respectively survival rates of one,two and three years were 76.6%,55.5%,40. 05 and 49.0%,31.0%,21.0%(P0.05).respectively disease free survival rates of one,two and three years were 70.2%, 43.2%,22.0% and 42.0%,20.5%,18.0%(P0.05).respectively survival rate and disease free survival rate of study group were higher than control group.The side effect of study group(30.0%)was higher than control group(6.3%)(P0.05).Con- clusion:Radiotherapy combined with chemotherapy for esophageal carcinoma has synergistic action.
Key concepts: Medicine, Radiation therapy, Chemotherapy, Cisplatin, Internal medicine, Vinorelbine, Carcinoma, Survival rate